Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
Inclusion Criteria
- treated with oral agents in monotherapy or combined therapy ± basal insulin
- has type 2 diabetes
- previously educated to self-monitoring blood glucose (SMBG) use
- treated with oral agents in monotherapy or combined therapy ± basal insulin
- has type 2 diabetes
- previously educated to self-monitoring blood glucose (SMBG) use
Exclusion Criteria
- pregnancy
- has type 2 diabetes non-pharmacologically treated
- has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
- ...
- pregnancy
- has type 2 diabetes non-pharmacologically treated
- has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
- has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months
- has type 2 diabetes treated with multiple daily injections of insulin
- is unable to use the telemedicine system
Summary
- Conditions
- Type 2 Diabetes Mellitus
- Type
- Interventional
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
Participation Requirements
- Age
- Between 45 years and 125 years
- Gender
- Both males and females
Inclusion Criteria
- treated with oral agents in monotherapy or combined therapy ± basal insulin
- has type 2 diabetes
- previously educated to self-monitoring blood glucose (SMBG) use
- treated with oral agents in monotherapy or combined therapy ± basal insulin
- has type 2 diabetes
- previously educated to self-monitoring blood glucose (SMBG) use
Exclusion Criteria
- pregnancy
- has type 2 diabetes non-pharmacologically treated
- has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
- ...
- pregnancy
- has type 2 diabetes non-pharmacologically treated
- has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
- has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months
- has type 2 diabetes treated with multiple daily injections of insulin
- is unable to use the telemedicine system
Tracking Information
- NCT #
- NCT02194608
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon